“Each new therapeutic modality brings with it a host of bioanalytical challenges. Solving these problems will be the task for the next generation of bioanalyists. It thus makes me excited to be part of a group that will be evaluating the accomplishments of these rising stars.”
Dr Woolf currently directs the Clinical Regulated Bioanalysis Group of Merck Research Laboratories, West Point, PA. He received his B.A. in Chemistry from LaSalle College in 1982, and a Ph.D. in Analytical Chemistry from Seton Hall University in 1986. From 1986 to 1990 he was a member of the Drug Metabolism/Pharmacokinetics Dept. of Berlex Laboratories. He joined Merck Research Laboratories in 1990 as a research fellow. Dr. Woolf and his group have supported numerous clinical development projects that have led to the successful registration of Merck compounds. Since 1986, he has authored or co-authored over 50 research papers pertaining to bioanalysis and pharmacokinetics. His major research interests include the utilization of novel HPLC approaches in bioanalysis and the bioanalysis of unstable compounds.